The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on DeepVerge Collaboration

21 Oct 2021 07:00

RNS Number : 7339P
Microsaic Systems plc
21 October 2021
 

21 October 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Update on DeepVerge Collaboration

 

Microsaic (AIM: MSYS), is pleased to note the update by DeepVerge plc (AIM: DVRG) ("DeepVerge") provided today regarding their orders for pathogen monitoring equipment for shipment this year to partners and customers in UK, India and China, which includes upgrades to DeepVerge Modern Water Microtox® PD1 units and Microsaic mass spectrometer units. Configurations of the Microsaic equipment will be included in these orders to DeepVerge for the integrated detection of PFASs (Per- and Polyfluoroalkyl Substances or 'forever chemicals'), as referenced in previous Microsaic announcements on 25 May and 23 August, 2021. This monitoring capability forms part of broader integrated solutions offered by DeepVerge for monitoring toxicity and heavy metal pollutants as well as the prevalence of SARS-CoV-2 as part of the ongoing pandemic response.

Glenn Tracey, CEO of Microsaic commented:

"We are greatly encouraged to see the results of our collaboration with DeepVerge translating into early demand for Microsaic mass spectrometer units as part of a new point-of-need monitoring solution, providing the capability for real-time monitoring of PFASs or 'Forever Chemicals'. In addition, working with DeepVerge teams in York, UK and Cork, Ireland we can already see an important contribution being made in the use of our micro-engineering expertise in ongoing development and upgrading of DeepVerge Modern Water equipment, especially in the integrated approach to Artificial Intelligence ("AI") between our technologies.

"While small in terms of initial impact for Microsaic, we see these initial shipments as having the potential to seed further demand in key locations, particularly in India and China over time. The power of these surveillance solutions lies in their multi-tiered approach to environmental monitoring and control, from pandemic response (pathogen detection) to toxicity and chemicals of concern, and in their ability to monitor data on an ongoing basis, recognising early threats and indicative patterns using AI." 

Microsaic notes that DeepVerge is a related party under the AIM Rules for Companies and its independent directors will review the details of any order(s) received from DeepVerge for its equipment when further details are made available in due course.

 

1 Microtox® PD has been designed to be retrofitted into existing Modern Water equipment to detect and identify a range of infectious viruses and bacteria including SARS-CoV-2, E.coli, Legionella and Cryptosporidium, on a single chip, using AI, in real-time

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO / Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

About Microsaic

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. DeepVerge is utilising artificial intelligent data analytics to prove scientifically the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and to detect remotely, and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMMBRTMTJTBMB
Date   Source Headline
23rd Feb 20212:13 pmRNSHolding(s) in Company
16th Feb 20219:00 amRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSFramework Services Agreement
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20215:59 pmRNSHolding(s) in Company
8th Feb 20215:58 pmRNSHolding(s) in Company
8th Feb 202111:08 amRNSHolding(s) in Company
8th Feb 202111:06 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
5th Feb 20215:02 pmRNSHolding(s) in Company
5th Feb 20213:22 pmRNSHolding(s) in Company
5th Feb 20218:05 amRNSDirector/PDMR Shareholding
5th Feb 20218:01 amRNSBoard Changes
4th Feb 202110:22 amRNSResult of General Meeting
29th Jan 20212:05 pmRNSSecond Price Monitoring Extn
29th Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 20215:26 pmRNSFull Exercise of Broker Option
19th Jan 20212:06 pmRNSSecond Price Monitoring Extn
19th Jan 20212:00 pmRNSPrice Monitoring Extension
19th Jan 202111:05 amRNSSecond Price Monitoring Extn
19th Jan 202111:00 amRNSPrice Monitoring Extension
19th Jan 20219:05 amRNSSecond Price Monitoring Extn
19th Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSFundraising, Board Changes and Notice of GM
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSStatement re. share price movement
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
22nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:01 pmRNSPrice Monitoring Extension
22nd Dec 202011:05 amRNSSecond Price Monitoring Extn
22nd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSEnd of Formal Sale Process
15th Dec 202010:49 amRNSForm 8.3 - Microsaic Systems plc
9th Dec 202012:10 pmRNSForm 8.5 (EPT/RI)
9th Dec 202010:17 amRNSForm 8.3 - Microsaic Systems plc
8th Dec 20203:32 pmRNSForm 8.3 - Microsaic Systems plc
8th Dec 202011:33 amRNSForm 8.5 (EPT/RI)
7th Dec 20204:33 pmRNSForm 8.3 - Microsaic Systems plc
7th Dec 202011:00 amRNSForm 8.5 (EPT/RI)
4th Dec 202010:11 amRNSForm 8.5 (EPT/RI)
26th Nov 202011:59 amRNSForm 8.5 (EPT/RI)
25th Nov 20204:48 pmRNSForm 8.3 - MICROSAIC SYSTEMS PLC
24th Nov 202010:04 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.